Alicia Zhou

Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2020 Event

2021 Event

LLC Menu Official

LLC Menu

Cofounder CEO

Ally Tam Tumasova

Dr. Alicia Zhou, PhD, serves as the Chief Executive Officer of the Cancer Research Institute (CRI), a premier global nonprofit driving transformative advances in cancer immunotherapy. Under her leadership, CRI is at the forefront of harnessing the immune system to fight and ultimately cure all cancers. Since 1953, CRI has invested over $500 million into groundbreaking research programs that bridge laboratory innovations with clinical applications, profoundly transforming cancer treatment and improving patient outcomes.
Before joining CRI, Dr. Zhou was the Chief Science Officer at Color Health, where she led initiatives to improve patients’ access to cancer prevention and screening towards better patient outcomes and population health. Additionally, she played a key role as a Steering Committee member and Principal Investigator for the National Institutes of Health (NIH)’s All of Us Research Program. This landmark initiative aims to ensure equitable and accessible precision medicine for all Americans. Dr. Zhou’s exceptional leadership and contributions were recognized in 2021 when she was named one of San Francisco Business Times’ 40 Under 40 and featured on Fierce Healthcare’s Most Influential Minority Executives List.
Dr. Zhou holds a B.S. in Biology from the Massachusetts Institute of Technology, a Ph.D. in Biological and Biomedical Sciences from Harvard University and completed her postdoctoral research in cancer biology at the University of California, San Francisco.


Tam is a consumer health and wellness investor-turned-operator, and cofounder CEO of Halle Berry's Respin Health, a digital health platform for menopause care and support. Tam was recognized by Forbes 30 Under 30 twice, first in 2019 and again in 2021 for her achievements as a venture capital investor. In her capacity as a venture investor, Tam deployed over $100 million in venture funding across primarily early stage consumer health/wellness and community-led companies, including Maven Clinic, Bobbie Baby, Co-Star, and Food52. Prior to founding Respin Health, Tam served as a Director of New Ventures at Redesign Health, a global venture studio dedicated to launching and scaling transformative healthcare companies. Her expertise sits at the intersection of consumer brand building, digital health, and technology.

Alan Silver is President of Ambetter Health Solutions business, which focuses on ICHRA (Individual Coverage Health Reimbursement Arrangements). This newly created role reflects Centene's belief that consumers increasingly will seek health insurance that offers transparency, customization, choice, and convenience. ICHRA plans allow employees to shop on the individual Marketplace and choose the insurance plan that works best for them, using a tax-free stipend from their employer.

Silver brings more than two decades of leadership experience in benefits administration and actuarial consulting to the role, including a proven record of driving growth, developing client-focused benefit solutions and pioneering exchange-based healthcare strategies. Most recently, Silver led retiree medical and ICHRA initiatives at Willis Towers Watson. His expertise uniquely positions him to lead Ambetter's efforts in expanding and enhancing ICHRA offerings to meet and drive evolving market needs.


President of ICHRA for Ambetter

Alan Silver